Citation Impact
Citing Papers
Treatment Response Assessment in IDH-Mutant Glioma Patients by Noninvasive 3D Functional Spectroscopic Mapping of 2-Hydroxyglutarate
2015 StandoutNobel
Phase III Trial of Chemoradiotherapy for Anaplastic Oligodendroglioma: Long-Term Results of RTOG 9402
2012
Randomized Double-Blind Placebo-Controlled Trial of Acetyl-L-Carnitine for the Prevention of Taxane-Induced Neuropathy in Women Undergoing Adjuvant Breast Cancer Therapy
2013
Results of a Pivotal Phase II Study of Brentuximab Vedotin for Patients With Relapsed or Refractory Hodgkin's Lymphoma
2012 Standout
Phase III Trial of Chemotherapy Plus Radiotherapy Compared With Radiotherapy Alone for Pure and Mixed Anaplastic Oligodendroglioma: Intergroup Radiation Therapy Oncology Group Trial 9402
2006
Benefit From Procarbazine, Lomustine, and Vincristine in Oligodendroglial Tumors Is Associated With Mutation of IDH
2014
Randomized study of a short course of weekly cisplatin with or without amifostine in advanced head and neck cancer
1999
Lapatinib plus Capecitabine for HER2-Positive Advanced Breast Cancer
2006 Standout
Identification of delta/notch‐like epidermal growth factor‐related receptor as the Tr antigen in paraneoplastic cerebellar degeneration
2012
Ma1, a novel neuron- and testis-specific protein, is recognized by the serum of patients with paraneoplastic neurological disorders
1999
Neurotoxicity of taxanes: Symptoms and quality of life assessment
2004
Phase III Randomized Trial of Docetaxel-Carboplatin Versus Paclitaxel-Carboplatin as First-line Chemotherapy for Ovarian Carcinoma
2004
North Central Cancer Treatment Group/Alliance trial N08CA—the use of glutathione for prevention of paclitaxel/carboplatin‐induced peripheral neuropathy: A phase 3 randomized, double‐blind, placebo‐controlled study
2014
rhGGF2 protects against cisplatin-induced neuropathy in the rat
2000
Neurologic Complications of the Reactivation of Varicella–Zoster Virus
2000 Standout
Sjögren's syndrome
2005 Standout
Biodegradable nanoparticles for drug and gene delivery to cells and tissue
2003 Standout
Diagnosis and Treatment of Low Back Pain: A Joint Clinical Practice Guideline from the American College of Physicians and the American Pain Society
2007 Standout
Ovarian cancer
2014 Standout
Paraneoplastic Syndromes Involving the Nervous System
2003 Standout
Metastatic non-small-cell lung cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
2016 Standout
Nociceptive Signals Induce Trafficking of TRPA1 to the Plasma Membrane
2009 StandoutNobel
Anti-amphiphysin I antibodies in patients with paraneoplastic neurological disorders associated with small cell lung carcinoma
1999
Glioblastoma and Other Malignant Gliomas
2013 Standout
Afatinib versus cisplatin plus gemcitabine for first-line treatment of Asian patients with advanced non-small-cell lung cancer harbouring EGFR mutations (LUX-Lung 6): an open-label, randomised phase 3 trial
2014 Standout
Recommended diagnostic criteria for paraneoplastic neurological syndromes
2004 Standout
Osimertinib or Platinum–Pemetrexed in EGFR T790M–Positive Lung Cancer
2016 Standout
Hepatic encephalopathy in chronic liver disease: 2014 Practice Guideline by the American Association for the Study Of Liver Diseases and the European Association for the Study of the Liver
2014 Standout
Carcinoma associated paraneoplastic peripheral neuropathies in patients with and without anti-onconeural antibodies
1999
The patterns of varicella zoster virus encephalitis
1996
Carbonic anhydrase–related protein VIII: Autoantigen in paraneoplastic cerebellar degeneration
2004
Weekly high-dose cisplatin is a feasible treatment option: analysis on prognostic factors for toxicity in 400 patients
2003
Headache related to brain tumors
2006
Bevacizumab plus Radiotherapy–Temozolomide for Newly Diagnosed Glioblastoma
2014 Standout
Paraneoplastic Neurologic Syndromes: Pathogenesis and Physiopathology
1999
Drug Resistance Towards Etoposide and Cisplatin in Human Melanoma Cells is Associated with Drug-Dependent Apoptosis Deficiency
2002
Paraneoplastic antibodies detected by isoelectric focusing of cerebrospinal fluid and serum
2004
The Total Neuropathy Score: A Tool for Measuring Chemotherapy-Induced Peripheral Neuropathy
2008
Guidelines on management of low‐grade gliomas: report of an EFNS–EANO* Task Force
2010
Therapy for paraneoplastic neurologic syndromes in six patients with protein a column immunoadsorption
1995
Paraneoplastic anti– N ‐methyl‐ D ‐aspartate receptor encephalitis associated with ovarian teratoma
2007 Standout
Screening for tumours in paraneoplastic syndromes: report of an EFNS Task Force
2010
Anaplastic Oligodendroglioma and Oligoastrocytoma
2007
Multicenter phase II trial of temozolomide in patients with glioblastoma multiforme at first relapse
2001
Potassium channel antibody‐associated encephalopathy: a potentially immunotherapy‐responsive form of limbic encephalitis
2004 Standout
The Validity of Neuropathy and Neuropathic Pain Measures in Patients With Cancer Receiving Taxanes and Platinums
2011
Medical management of patients with brain tumors
2006
Malignant Gliomas in Adults
2008 Standout
Voltage‐gated potassium channel antibodies in limbic encephalitis
2003
The development and modulation of nociceptive circuitry
2006
Direct decompressive surgical resection in the treatment of spinal cord compression caused by metastatic cancer: a randomised trial
2005 Standout
Antiamphiphysin Antibodies Are Associated With Various Paraneoplastic Neurological Syndromes and Tumors
1999
Spectrum of Paraneoplastic Neurologic Disorders in Women with Breast and Gynecologic Cancer
2003
2B4 stimulation of YT cells induces natural killer cell cytolytic function and invasiveness
2000
Microtubule-binding agents: a dynamic field of cancer therapeutics
2010 Standout
Neuronal autoantigens—pathogenesis, associated disorders and antibody testing
2012
The blood-brain barrier and oncology: new insights into function and modulation
2000
N-methyl-d-aspartate antibody encephalitis: temporal progression of clinical and paraclinical observations in a predominantly non-paraneoplastic disorder of both sexes
2010 Standout
Paraneoplastic demyelinating neuropathy, subacute sensory neuropathy, and anti-hu antibodies: Clinicopathological study of an autopsy case
1998
Paraneoplastic Cerebellar Ataxia Due to Autoantibodies against a Glutamate Receptor
2000
Effect of Duloxetine on Pain, Function, and Quality of Life Among Patients With Chemotherapy-Induced Painful Peripheral Neuropathy
2013 Standout
Primary brain tumours in adults
2012 Standout
Treatment and prognostic factors for long-term outcome in patients with anti-NMDA receptor encephalitis: an observational cohort study
2013 Standout
Survey of treatment recommendations for anaplastic oligodendroglioma
2007
The biopsychosocial approach to chronic pain: Scientific advances and future directions.
2007 Standout
Cisplatin in cancer therapy: Molecular mechanisms of action
2014 Standout
Current therapies for paraneoplastic neurologic syndromes
2003
Pharmacotherapy for neuropathic pain in adults: a systematic review and meta-analysis
2015 Standout
Free radicals and antioxidants in chemotherapyinduced toxicity
1997
Serum autoantibodies in childhood opsoclonus-myoclonus syndrome: An analysis of antigenic targets in neural tissues
1997
Astrocyte–endothelial interactions at the blood–brain barrier
2005 Standout
Case report A reversible neuronal antibody (anti-Tr) associated paraneoplastic cerebellar degeneration in Hodgkin's disease
2009
The cerebellar cognitive affective syndrome
1998 Standout
Clinical outcome in adult onset idiopathic or paraneoplastic opsoclonus-myoclonus
2001
Metastatic non-small cell lung cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
2018 Standout
Metastatic non-small-cell lung cancer (NSCLC): ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
2012
Lack of neuroprotection by an ACTH (4?9) analogue. A randomized trial in patients treated with vincristine for Hodgkin?s or non-Hodgkin?s lymphoma
2004
High-grade malignant glioma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
2010
Neurocognition in patients with brain metastases treated with radiosurgery or radiosurgery plus whole-brain irradiation: a randomised controlled trial
2009 Standout
Clinical experience and laboratory investigations in patients with anti-NMDAR encephalitis
2010 Standout
Neurologic Manifestations in Primary Sjögren Syndrome
2004
Utility of anti‐Hu antibodies in the diagnosis of paraneoplastic sensory neuropathy
1998
The management of brain edema in brain tumors
2004
Anti-Yo Positive Paraneoplastic Cerebellar Degeneration Associated with Ovarian Carcinoma: Case Report and Review of the Literature
1999
Paraneoplastic limbic encephalitis: neurological symptoms, immunological findings and tumour association in 50 patients
2000 Standout
Autoantibodies to Synaptic Receptors and Neuronal Cell Surface Proteins in Autoimmune Diseases of the Central Nervous System
2017
Atezolizumab for First-Line Treatment of Metastatic Nonsquamous NSCLC
2018 Standout
Antibody-Mediated Encephalitis
2018 Standout
Biochemical Modulation of Cisplatin Mechanisms of Action: Enhancement of Antitumor Activity and Circumvention of Drug Resistance
2003 Standout
The interaction of TIGIT with PVR and PVRL2 inhibits human NK cell cytotoxicity
2009 Standout
Spinal Cord Compression from Epidural Metastases
1992
Correlations Between O6-Methylguanine DNA Methyltransferase Promoter Methylation Status, 1p and 19q Deletions, and Response to Temozolomide in Anaplastic and Recurrent Oligodendroglioma: A Prospective GICNO Study
2006
Interventions for preventing neuropathy caused by cisplatin and related compounds
2014
P/Q type calcium-channel antibodies in paraneoplastic cerebellar degeneration with lung cancer
2002
The Three Es of Cancer Immunoediting
2004 Standout
Isolation and Characterization of Tumorigenic, Stem-like Neural Precursors from Human Glioblastoma
2004 Standout
Bevacizumab and chemotherapy for recurrent glioblastoma
2009
Interventions for the treatment of metastatic extradural spinal cord compression in adults
2015
Paraneoplastic cerebellar degeneration associated with antineuronal antibodies: analysis of 50 patients
2003
CBTRUS Statistical Report: Primary Brain and Central Nervous System Tumors Diagnosed in the United States in 2006-2010
2013 Standout
Anti-Tr antibodies as markers of paraneoplastic cerebellar degeneration and Hodgkin’s disease
2003
Phase III Trial of Nanoparticle Albumin-Bound Paclitaxel Compared With Polyethylated Castor Oil–Based Paclitaxel in Women With Breast Cancer
2005 Standout
Neuro-ophthalmologic manifestations of a paraneoplastic syndrome and testicular carcinoma
1999
Impairment‐driven cancer rehabilitation: An essential component of quality care and survivorship
2013
Peripheral Neuropathy Induced by Microtubule-Stabilizing Agents
2006
Paraneoplastic Neurologic Disease Antigens: RNA-Binding Proteins and Signaling Proteins in Neuronal Degeneration
2001
Complementary/Alternative Medicine Use in a Comprehensive Cancer Center and the Implications for Oncology
2000 Standout
Limbic encephalitis as a precipitating event in adult-onset temporal lobe epilepsy
2007
NCCN Task Force Report: Management of Neuropathy in Cancer
2009
Limbic encephalitis not associated with neoplasm as a cause of temporal lobe epilepsy
2000
Prevention and Management of Chemotherapy-Induced Peripheral Neuropathy in Survivors of Adult Cancers: American Society of Clinical Oncology Clinical Practice Guideline
2014 Standout
Management of brain metastases
2016
Pharmacological Effects of Formulation Vehicles
2003
Cancer treatment and survivorship statistics, 2019
2019 Standout
Herpes zoster ophthalmicus and delayed contralateral hemiparesis caused by cerebral angiitis: Diagnosis and management approaches
1983
[18F]Fluorodeoxyglucose positron emission tomography in the diagnosis of cancer in patients with paraneoplastic neurological syndrome and anti-Hu antibodies
2000
Metastatic Behavior of Breast Cancer Subtypes
2010 Standout
Temozolomide As Initial Treatment for Adults With Low-Grade Oligodendrogliomas or Oligoastrocytomas and Correlation With Chromosome 1p Deletions
2004
Systematic Review of the Diagnosis and Management of Malignant Extradural Spinal Cord Compression: The Cancer Care Ontario Practice Guidelines Initiative‘s Neuro-Oncology Disease Site Group
2005
CNS Metastases in Breast Cancer
2004
Works of Ch.J. Vecht being referenced
The diagnostic accuracy of magnetic resonance imaging and cerebrospinal fluid cytology in leptomeningeal metastasis
1999
Clinical course and risk factors of neurotoxicity following cisplatin in an intensive dosing schedule
1994
Immunological characterization of a neuronal antibody (anti-Tr) associated with paraneoplastic cerebellar degeneration and Hodgkin's disease
1997
Intrathecal injection of GDNF and BDNF induces immediate early gene expression in rat spinal dorsal horn
2005
Neurotoxicity is not enhanced by increased dose intensities of cisplatin administration
1995
The effect of dexamethasone on the uptake of cisplatin in 9L glioma and the area of brain around tumor
1998
Peripheral neurotoxicity induced by docetaxel
1996
Initial bolus of conventional versus high‐dose dexamethasone in metastatic spinal cord compression
1989
Phase II Study of Weekly Dose-intensified Cisplatin Chemotherapy with Oral Etoposide in Recurrent Glioma
1999
The Accumulation of Topotecan in 9L Glioma and in Brain Parenchyma with and without Dexamethasone Administration
1999
Guidelines on the detection of paraneoplastic anti-neuronal-specific antibodies
1995
Phase II study on cisplatin and ifosfamide in recurrent high grade gliomas
1998
Phase II study of a short course of weekly high-dose cisplatin combined with long-term oral etoposide in metastatic malignant melanoma
1996
Hemispheric infarction after herpes zoster ophthalmicus
1982
Brain tumor invasiveness
1995
The effects of an ACTH (4?9) analogue on development of cisplatin neuropathy in testicular cancer: A randomized trial
1994
Involvement of the peripheral nervous system in primary Sjögren's syndrome
2001
Antineuronal antibodies in patients with neurologic complicat'lons of primary Sjogren's syndrome
1993
Phase II Study of First-Line Chemotherapy With Temozolomide in Recurrent Oligodendroglial Tumors: The European Organization for Research and Treatment of Cancer Brain Tumor Group Study 26971
2003
Dose‐effect relationship of dexamethasone on Karnofsky performance in metastatic brain tumors
1994